首页> 外文期刊>Cardiology >Aortic valve replacement with and without coronary artery bypass graft surgery in octogenarians: Is it safe and feasible?
【24h】

Aortic valve replacement with and without coronary artery bypass graft surgery in octogenarians: Is it safe and feasible?

机译:高龄者在有或没有冠状动脉搭桥手术的情况下进行主动脉瓣置换术是否安全可行?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Introduction: Octogenarians are often denied complex surgical intervention. We evaluated the rationality of this bias by comparing the outcomes of octogenarians undergoing aortic valve replacement (AVR) with or without coronary artery bypass grafting (CABG), to those of younger patients. Methods: Data on 476 patients (??80 years) who underwent AVR or AVR/CABG were compared to the Society of Thoracic Surgeons (STS) database. Results: One hundred and seventeen octogenarians underwent AVR and 263 underwent AVR/CABG. Preoperative comorbidity rates were similar between these 2 respective groups, except for diabetes mellitus (18.8 vs. 30.4%, p = 0.02), previous cardiac stent placement (5.1 vs. 17.9%, p = 0.0006) and prior CABG (8.5 vs. 0.8%, p = 0.0002) and mortality did not differ significantly (5.1 vs. 7.6%, p = 0.51). Multivariate analysis identified preoperative chronic renal failure [odds ratio (OR) = 0.09, p < 0.048], postoperative arrhythmia (OR = 0.29, p < 0.022), sepsis (OR = 37.38, p < 0.000), pneumonia (OR = 8.29, p < 0.038) and renal failure (OR = 10.16, p < 0.000) with increased rates of inhospital mortality in AVR alone and AVR/CABG. Conclusion: AVR alone or AVR/CABG can be safely performed in patients ?? 80 years with acceptable morbidity/mortality rates. An age of ?? 80 years is not an independent risk factor predictive of increased inhospital mortality.
机译:简介:八面体患者经常被拒绝进行复杂的手术干预。我们通过比较接受或不接受冠状动脉旁路移植术(CABG)的接受主动脉瓣置换术(AVR)的高龄患者与年轻患者的结果,评估了这种偏倚的合理性。方法:将接受AVR或AVR / CABG的476例患者(约80岁)的数据与胸外科医师协会(STS)数据库进行比较。结果:一百一十七名八岁老人接受了AVR,263名接受了AVR / CABG。这两组患者的术前合并症发生率相似,除了糖尿病(18.8 vs. 30.4%,p = 0.02),先前的心脏支架置入(5.1 vs. 17.9%,p = 0.0006)和先前的CABG(8.5 vs. 0.8)。 %,p = 0.0002)和死亡率无显着差异(5.1比7.6%,p = 0.51)。多因素分析确定了术前慢性肾功能衰竭[几率(OR)= 0.09,p <0.048],术后心律失常(OR = 0.29,p <0.022),败血症(OR = 37.38,p <0.000),肺炎(OR = 8.29, p <0.038)和肾衰竭(OR = 10.16,p <0.000),单独使用AVR和AVR / CABG的住院死亡率增加。结论:单独使用AVR或AVR / CABG可以安全地治疗患者。 80年的可接受的发病率/死亡率。年龄?? 80岁并不是预测院内死亡率增加的独立危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号